Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 10INDUSTRY 7OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Fallopian Tube Neoplasms 1

Interventions

taxane 2Surgical Procedures, Operative 2Poly(ADP-ribose) Polymerase Inhibitors 2Neoadjuvant Therapy 2Carboplatin 2Bevacizumab 2olaparib 1niraparib 1cediranib 1Platinum 1Paclitaxel 1Maintenance 1Etoposide 1Drug Therapy 1Diagnostic Imaging 1CP protocol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Fallopian Tube Neoplasms × niraparib × Clear all
NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
167 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡